E-Mail:
Password:
Home | Stock Market Blogs | Financial Tools | Sign Up Free
 

gear headHow cool is this? Shampoo for men in a quart of oil bottle!

Click the banner to get some now and tell the little lady to throw that other stuff in the trash!
KERYX BIOPHARMACEU  
KERYX BIOPHARMACEU
KERXLast: $4.21 ($+0.10)Volume: 2,045,512Last Trade: 8/5/2010 5:20:01 PM
Today

Today | Last 7 Days | 1 Month | 3 Month | 6 Month | 1 Year
 Options
Quote |  Alerts | | Free Newsletter
 
 Detailed Quote
NASDAQ:KERX $4.21 ($+0.10 +2.433%)
Industry: Health Sector: Pharmaceuticals
Open: 4.06 Previous Close: 4.11
Day's High: 4.34 Day's Low: 4.05
52-Week High: 12.89 52-Week Low: 5.35
 
Bid: 4.20 / 8,100 Ask: 4.21 / 6,800
Volume: 2,045,512 Outstanding: 0
Market Cap: -
KERYX BIOPHARMACEU Profile
Keryx Biopharmaceuticals is a biopharmaceutical company focused on the acquisition, development and commercialization of novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer. Co.'s lead compound under development is Sulonex? (sulodexide), a first-in-class, oral heparinoid compound for the treatment of diabetic nephropathy, a life-threatening kidney disease caused by diabetes. Additionally, Co. is developing Zerenex? , an oral, inorganic, iron-based compound, as well as clinical-stage oncology compounds, including KRX-0401 , a novel, first-in-class, oral anti-cancer agent. Co. also has an active in-licensing and acquisition program.
 KERYX BIOPHARMACEU News & Press Releases

Keryx Biopharmaceuticals, Inc. Announces First Quarter 2010 Financial Results
NEW YORK , May 10 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. ( KERX ), a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products fo... [more]

Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2009 Financial Results
NEW YORK , March 24 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. ( KERX ), a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products... [more]

Keryx Biopharmaceuticals, Inc. To Hold Conference Call on Fourth Quarter and Year-End 2009 Financial
NEW YORK , March 23 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. ( KERX ) will hold a conference call on Thursday, March 25, 2010 at 8:30 a.m. EDT to discuss the fourth quarter and year... [more]

Keryx Biopharmaceuticals (NASDAQ: KERX) Responds to Erroneous Report About Planned Phase III Study f
LOS ANGELES, CA -- (Marketwire) -- 02/05/10 -- BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, is reporting that Keryx Biop... [more]

Beacon Equity issues Trading Overview for Keryx Biopharmaceuticals
( EMAILWIRE.COM , October 15, 2009 ) DALLAS, Texas - BeaconEquity.com announces an investment report featuring Keryx Biopharmaceuticals (Nasdaq:KERX). The investment report on Keryx Biopharmaceuticals (Nasdaq: KERX) should be of particul... [more]

Keryx Biopharmaceuticals, Inc. to Raise $20 Million in Registered Direct Offering
NEW YORK, Sept. 25 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (the "Company") ( KERX ), has entered into definitive agreements to sell 8 million shares of its common stock at a price per sh... [more]

Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2008 Financial Results
Keryx to Host Investor Conference Call on Friday, March 13, 2009 at 8:30am EDT NEW YORK , March 12 /PRNewswire-FirstCall/ -- Keryx Biopharmaceutic... [more]

Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year-End 2008 Financial
NEW YORK , March 11 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. ( KERX ) will hold a conference call on Friday, March 13, 2009 at 8:30 a.m. EDT to... [more]

Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2008 Financial Results
NEW YORK , Nov. 10 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. ( KERX ), a biopharmaceutical company focused on the acquisition, development and commercialization of med... [more]

Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2008 Financial Results on Tu
NEW YORK , Nov. 7 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. ( KERX ) will hold a conference call on Tuesday, November 11, 2008 at 8:30 a.m. EST t... [more]

Keryx Biopharmaceuticals Notified that Nasdaq Has Extended Minimum Bid Price Rule Compliance Period
NEW YORK , Oct. 23 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. ( KERX ) announced today that it has received notice from The Nasdaq Stock Market ("Nasdaq") stating that Nasd... [more]

Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results
NEW YORK , Aug. 8 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. ( KERX ), a biopharmaceutical company focused on the acquisition, development and commercialization of medi... [more]

Keryx Biopharmaceuticals, Inc. Announces First Quarter 2008 Financial Results
NEW YORK, May 9 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. KERX , a biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatme... [more]

Keryx Biopharmaceuticals, Inc. to Hold Conference Call on First Quarter 2008 Financial Results on Mo
NEW YORK, May 8 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. KERX will hold a conference call on Monday, May 12, 2008 at 8:30 a.m. EDT to discuss the first quarter 2008 financial results. Michael S. Weiss, Chairman and Chief E... [more]

Keryx Biopharmaceuticals Receives Nasdaq Notification
NEW YORK, April 25 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. KERX announced today that it has received notice from The NASDAQ Stock Market ("Nasdaq") stating that the Company is not in compliance with the $1.00 minimum bid... [more]


Home | Blogs | Savings Calculator | Tools | Contact Us | Disclosure | Site Map | Sign UpCopyright 2014
SmallCapWatch, LLC.
Never invest based soley on information from this website or our e-mail and IM alerts